First Circuit affirms $142 million verdict against Pfizer in three Neurontin cases.

By: Chris Placitella @ Apr 05, 2013

The First Circuit Court of Appeals changed the landscape for third-party payor cases involving defective pharmaceuticals. The opinions are important in terms of how plaintiffs go about proving their cases from a causation and damages perspective. The First Circuit yesterday materially softened the individual proof rule and is willing to allow in aggregate proof in […]

https://www.chrisplacitella.com/2013/04/05/first-circuit-affirms-142-million-verdict-against-pfizer-in-three-neurontin-cases/

Brought to you by:

CPR Law

2001 Market Street, Suite 2900
Philadelphia,
Pennsalvania
19103

Phone: (215) 567-3500
https://cprlaw.com/pennsylvania/
https://cprlaw.com/pa/philadelphia/

Disclaimer: The law firm of Cohen, Placitella & Roth, P.C. only provides legal advice after it has entered into an attorney-client relationship, which this website specifically does not create. Only after having entered into a written, signed agreement with the law firm of Cohen, Placitella & Roth, P.C. will an attorney-client relationship have been created. It is imperative that any action taken be done on the advice of counsel. Because every case is different, the descriptions of awards and cases previously handled are not meant to be a guarantee of success. Cohen, Placitella & Roth, a National Personal Injury, Mesothelioma, Birth Injury and Medical Malpractice Law Firm with Offices in Pennsylvania and New Jersey

First Circuit affirms $142 million verdict against Pfizer in three Neurontin cases.

Archives

Categories